147
Views
12
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma

, , , , , , & show all
Pages 1678-1685 | Received 20 Dec 2009, Accepted 02 Jun 2010, Published online: 31 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gonçalo Boleto, David Saadoun & Patrice Cacoub. (2020) Strategies to prevent persistent or relapsed mixed cryoglobulinemia. Expert Opinion on Orphan Drugs 8:5, pages 137-143.
Read now
Chadi Nabhan, Sonali M. Smith & Brad S. Kahl. (2012) Maintenance rituximab in follicular non-Hodgkin lymphoma: facts and controversies. Leukemia & Lymphoma 53:5, pages 770-778.
Read now
Philip A. Thompson, Constantine S. Tam, Karin Thursky & John F. Seymour. (2010) Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge. Leukemia & Lymphoma 51:9, pages 1592-1595.
Read now

Articles from other publishers (9)

Andrea Núñez-Conde, Ignasi Rodríguez-Pintó, David A. Alba-Garibay, Alba Álvarez-Abella, Alba Jerez-Lienas, Oriol Llargués, M. Antonio Alba-Sánchez, Diana Oleas & Marco A. Alba. (2023) Nonviral cryoglobulinemic vasculitis: an updated review for clinical practice. Vessel Plus.
Crossref
Chieh Liu, Yi-Fen Shih & Chun-Jen Liu. (2022) Immunopathogenesis of Acute Flare of Chronic Hepatitis B: With Emphasis on the Role of Cytokines and Chemokines. International Journal of Molecular Sciences 23:3, pages 1407.
Crossref
Dario Roccatello, David Saadoun, Manuel Ramos-Casals, Athanasios G. Tzioufas, Fernando C. Fervenza, Patrice Cacoub, Anna Linda Zignego & Clodoveo Ferri. (2018) Cryoglobulinaemia. Nature Reviews Disease Primers 4:1.
Crossref
Xing Li, Xiang Zhong, Zhan-Hong Chen, Tian-Tian Wang, Xiao-Kun Ma, Yan-Fang Xing, Dong-Hao Wu, Min Dong, Jie Chen, Dan-Yun Ruan, Ze-Xiao Lin, Jing-Yun Wen, Li Wei, Xiang-Yuan Wu & Qu Lin. (2016) Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization. Asian Pacific Journal of Cancer Prevention 16:18, pages 8665-8670.
Crossref
Xing Li, Xiang Zhong, Zhan-Hong Chen, Yan-Fang Xing, Dong-Hao Wu, Jie Chen, Xiao-Kun Ma, Qu Lin, Jing-Yun Wen, Li Wei, Tian-Tian Wang, Dan-Yun Ruan, Ze-Xiao Lin, Xiang-Yuan Wu & Min Dong. (2014) Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients. Asian Pacific Journal of Cancer Prevention 15:22, pages 9635-9641.
Crossref
Xiang-Yuan Wu, Xing Li, Zhan-Hong Chen, Jing-Yun Wen, Qu Lin, Yan-Fang Xing, Min Dong, Li Wei, Tian-Tian Wang, Jie Chen, Ze-Xiao Lin, Xiang-bo Wan, Dan-Yun Ruan & Xiao-Kun Ma. (2012) An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study. Tumor Biology 34:2, pages 909-918.
Crossref
Harrys A. Torres & Marta Davila. (2012) Authors' reply: Current strategies in the management of hepatitis B virus reactivation. Nature Reviews Clinical Oncology 9:6, pages 350-350.
Crossref
Xing Li, Yan-Fang Xing, Qu Lin, Min Dong, Xiang-Bo Wan & Xiang-Yuan Wu. (2012) The treatment of severe hepatitis B virus reactivation after chemotherapy. Nature Reviews Clinical Oncology 9:6, pages 350-350.
Crossref
. (2011) Current World Literature. Current Opinion in Oncology 23:5, pages 537-546.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.